Karen Bergman | Vice President, Investor Relations and Corporate Communications |
Tom Neff | Chairman, Founder, and Chief Executive Officer |
Peony Yu | Chief Medical Officer |
Elias Kouchakji | Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance |
Pat Cotroneo | Chief Financial Officer |
Wayne Frost | Senior Vice President, Regulatory Affairs |
Michael Yee | Jefferies |
Joel Beatty | Citi |
Terence Flynn | Goldman Sachs |
Geoffrey Porges | Silicon Valley Bank Leerink |
Difei Yang | Mizuho Securities |
Edwin Zhang | Stifel |
Welcome to the FibroGen’s First Quarter 2019 Financial Results Conference Call. My name is Erin, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note this conference is being recorded.